Publication Information

{'id': 'https://openalex.org/W4290997406', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.5086a', 'title': 'LB0005 ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON’S TYROSINE KINASE (BTK), FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IB/IIA DOSE-FINDING STUDY', 'display_name': 'LB0005 ORELABRUTINIB, AN IRREVERSIBLE INHIBITOR OF BRUTON’S TYROSINE KINASE (BTK), FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IB/IIA DOSE-FINDING STUDY', 'publication_year': 2022, 'publication_date': '2022-05-23', 'ids': {'openalex': 'https://openalex.org/W4290997406', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.5086a'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.5086a', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/210.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/210.2.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5057521694', 'display_name': 'R. Li', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210124809', 'display_name': "Peking University People's Hospital", 'ror': 'https://ror.org/035adwg89', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210124809']}, {'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'R. Li', 'raw_affiliation_strings': ["Peking University People's Hospital, Department of Rheumatology & Immunology, Beijing, China"], 'affiliations': [{'raw_affiliation_string': "Peking University People's Hospital, Department of Rheumatology & Immunology, Beijing, China", 'institution_ids': ['https://openalex.org/I4210124809', 'https://openalex.org/I20231570']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5035337227', 'display_name': 'X. Zhu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I24943067', 'display_name': 'Fudan University', 'ror': 'https://ror.org/013q1eq08', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I24943067']}, {'id': 'https://openalex.org/I4210159575', 'display_name': 'Huashan Hospital', 'ror': 'https://ror.org/05201qm87', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210159575']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'X. Zhu', 'raw_affiliation_strings': ['Huashan Hospital, Fudan University, Department of Rheumatology & Immunology, Shanghai, China'], 'affiliations': [{'raw_affiliation_string': 'Huashan Hospital, Fudan University, Department of Rheumatology & Immunology, Shanghai, China', 'institution_ids': ['https://openalex.org/I24943067', 'https://openalex.org/I4210159575']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079272189', 'display_name': 'S. Liu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210156804', 'display_name': 'First Affiliated Hospital of Zhengzhou University', 'ror': 'https://ror.org/056swr059', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210156804']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'S. Liu', 'raw_affiliation_strings': ['The First Affiliated Hospital of Zhengzhou University, Department of Rheumatology & Immunology, Zhengzhou, China'], 'affiliations': [{'raw_affiliation_string': 'The First Affiliated Hospital of Zhengzhou University, Department of Rheumatology & Immunology, Zhengzhou, China', 'institution_ids': ['https://openalex.org/I4210156804']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084295823', 'display_name': 'X. Zhang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210153930', 'display_name': "Guangdong Provincial People's Hospital", 'ror': 'https://ror.org/045kpgw45', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153930']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'X. Zhang', 'raw_affiliation_strings': ["Guangdong Provincial People's Hospital, Department of Rheumatology & Immunology, Guangzhou, China"], 'affiliations': [{'raw_affiliation_string': "Guangdong Provincial People's Hospital, Department of Rheumatology & Immunology, Guangzhou, China", 'institution_ids': ['https://openalex.org/I4210153930']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066824698', 'display_name': 'C. Xie', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210150172', 'display_name': 'First Affiliated Hospital of Bengbu Medical College', 'ror': 'https://ror.org/04v043n92', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210150172']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'C. Xie', 'raw_affiliation_strings': ['The First Affiliated Hospital of Bengbu Medical College, Department of Rheumatology & Immunology, Bengbu, China'], 'affiliations': [{'raw_affiliation_string': 'The First Affiliated Hospital of Bengbu Medical College, Department of Rheumatology & Immunology, Bengbu, China', 'institution_ids': ['https://openalex.org/I4210150172']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043399314', 'display_name': 'Z. Fu', 'orcid': 'https://orcid.org/0009-0002-4019-6733'}, 'institutions': [{'id': 'https://openalex.org/I4210125748', 'display_name': 'First Hospital of Shanxi Medical University', 'ror': 'https://ror.org/02vzqaq35', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210125748']}, {'id': 'https://openalex.org/I17721919', 'display_name': 'Shanxi Medical University', 'ror': 'https://ror.org/0265d1010', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I17721919']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Z. Fu', 'raw_affiliation_strings': ['First Hospital of Shanxi Medical University, Department of Rheumatology & Immunology, Taiyuan, China'], 'affiliations': [{'raw_affiliation_string': 'First Hospital of Shanxi Medical University, Department of Rheumatology & Immunology, Taiyuan, China', 'institution_ids': ['https://openalex.org/I4210125748', 'https://openalex.org/I17721919']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038604126', 'display_name': 'Anaoxue Huang', 'orcid': 'https://orcid.org/0009-0004-2027-9077'}, 'institutions': [{'id': 'https://openalex.org/I1318643470', 'display_name': 'Union Hospital', 'ror': 'https://ror.org/01j7r2734', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1318643470']}, {'id': 'https://openalex.org/I47720641', 'display_name': 'Huazhong University of Science and Technology', 'ror': 'https://ror.org/00p991c53', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I47720641']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'A. Huang', 'raw_affiliation_strings': ['Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Rheumatology & Immunology, Wuhan, China'], 'affiliations': [{'raw_affiliation_string': 'Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Rheumatology & Immunology, Wuhan, China', 'institution_ids': ['https://openalex.org/I1318643470', 'https://openalex.org/I47720641']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5008965146', 'display_name': 'L. Sun', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210111013', 'display_name': 'Nanjing Drum Tower Hospital', 'ror': 'https://ror.org/026axqv54', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210111013']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'L. Sun', 'raw_affiliation_strings': ['Nanjing Drum Tower Hospital, Department of Rheumatology & Immunology, Nanjing, China'], 'affiliations': [{'raw_affiliation_string': 'Nanjing Drum Tower Hospital, Department of Rheumatology & Immunology, Nanjing, China', 'institution_ids': ['https://openalex.org/I4210111013']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076728635', 'display_name': 'D. Liu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210105608', 'display_name': 'ShenZhen People’s Hospital', 'ror': 'https://ror.org/01hcefx46', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210105608']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'D. Liu', 'raw_affiliation_strings': ["Shenzhen People's Hospital, Department of Rheumatology & Immunology, Shenzhen, China"], 'affiliations': [{'raw_affiliation_string': "Shenzhen People's Hospital, Department of Rheumatology & Immunology, Shenzhen, China", 'institution_ids': ['https://openalex.org/I4210105608']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102907850', 'display_name': 'Jingrun Zhao', 'orcid': 'https://orcid.org/0000-0002-8214-626X'}, 'institutions': [{'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}, {'id': 'https://openalex.org/I4210141942', 'display_name': 'Peking University Third Hospital', 'ror': 'https://ror.org/04wwqze12', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210141942']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'J Zhao', 'raw_affiliation_strings': ['Peking University Third Hospital, Department of Rheumatology & Immunology, Beijing, China'], 'affiliations': [{'raw_affiliation_string': 'Peking University Third Hospital, Department of Rheumatology & Immunology, Beijing, China', 'institution_ids': ['https://openalex.org/I20231570', 'https://openalex.org/I4210141942']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066126967', 'display_name': 'Lan‐Tu‐Ya Wu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I889458895', 'display_name': 'University of Hong Kong', 'ror': 'https://ror.org/02zhqgq86', 'country_code': 'HK', 'type': 'education', 'lineage': ['https://openalex.org/I889458895']}, {'id': 'https://openalex.org/I4210141719', 'display_name': 'University of Hong Kong - Shenzhen Hospital', 'ror': 'https://ror.org/047w7d678', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210141719']}], 'countries': ['CN', 'HK'], 'is_corresponding': False, 'raw_author_name': 'L. Wu', 'raw_affiliation_strings': ['The University of Hong Kong Shenzhen Hospital, Department of Rheumatology & Immunology, Shenzhen, China'], 'affiliations': [{'raw_affiliation_string': 'The University of Hong Kong Shenzhen Hospital, Department of Rheumatology & Immunology, Shenzhen, China', 'institution_ids': ['https://openalex.org/I889458895', 'https://openalex.org/I4210141719']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5082877676', 'display_name': 'Z. Qin', 'orcid': None}, 'institutions': [], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Z. Qin', 'raw_affiliation_strings': ['InnoCare Pharma Limited, Department of Pharmacology, Beijing, China'], 'affiliations': [{'raw_affiliation_string': 'InnoCare Pharma Limited, Department of Pharmacology, Beijing, China', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014912247', 'display_name': 'S. Li', 'orcid': None}, 'institutions': [], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'S. Li', 'raw_affiliation_strings': ['InnoCare Pharma Limited, Department of Biostatics, Beijing, China'], 'affiliations': [{'raw_affiliation_string': 'InnoCare Pharma Limited, Department of Biostatics, Beijing, China', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041636303', 'display_name': 'Y. Liu', 'orcid': None}, 'institutions': [], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Y. Liu', 'raw_affiliation_strings': ['InnoCare Pharma Limited, Department of Autoimmune Medical Research, Beijing, China'], 'affiliations': [{'raw_affiliation_string': 'InnoCare Pharma Limited, Department of Autoimmune Medical Research, Beijing, China', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5058122003', 'display_name': 'Z. Li', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210124809', 'display_name': "Peking University People's Hospital", 'ror': 'https://ror.org/035adwg89', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210124809']}, {'id': 'https://openalex.org/I20231570', 'display_name': 'Peking University', 'ror': 'https://ror.org/02v51f717', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I20231570']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Z. Li', 'raw_affiliation_strings': ["Peking University People's Hospital, Department of Rheumatology & Immunology, Beijing, China"], 'affiliations': [{'raw_affiliation_string': "Peking University People's Hospital, Department of Rheumatology & Immunology, Beijing, China", 'institution_ids': ['https://openalex.org/I4210124809', 'https://openalex.org/I20231570']}]}], 'institution_assertions': [], 'countries_distinct_count': 2, 'institutions_distinct_count': 16, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 1.44, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.556131, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 83, 'max': 85}, 'biblio': {'volume': '81', 'issue': 'Suppl 1', 'first_page': '210.2', 'last_page': '210'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10952', 'display_name': 'PI3K/AKT/mTOR signaling in cancer', 'score': 0.9842, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11029', 'display_name': 'Renal Diseases and Glomerulopathies', 'score': 0.9839, 'subfield': {'id': 'https://openalex.org/subfields/2727', 'display_name': 'Nephrology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/tolerability', 'display_name': 'Tolerability', 'score': 0.711444}, {'id': 'https://openalex.org/keywords/pharmacodynamics', 'display_name': 'Pharmacodynamics', 'score': 0.41007024}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9415043}, {'id': 'https://openalex.org/C27081682', 'wikidata': 'https://www.wikidata.org/wiki/Q269829', 'display_name': 'Placebo', 'level': 3, 'score': 0.72039557}, {'id': 'https://openalex.org/C2778375690', 'wikidata': 'https://www.wikidata.org/wiki/Q7814214', 'display_name': 'Tolerability', 'level': 3, 'score': 0.711444}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.6790941}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.65201145}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.55219495}, {'id': 'https://openalex.org/C90059517', 'wikidata': 'https://www.wikidata.org/wiki/Q423572', 'display_name': "Bruton's tyrosine kinase", 'level': 4, 'score': 0.5322345}, {'id': 'https://openalex.org/C2777063308', 'wikidata': 'https://www.wikidata.org/wiki/Q1435822', 'display_name': 'Neutropenia', 'level': 3, 'score': 0.5313668}, {'id': 'https://openalex.org/C2776912625', 'wikidata': 'https://www.wikidata.org/wiki/Q1485', 'display_name': 'Systemic lupus erythematosus', 'level': 3, 'score': 0.49507108}, {'id': 'https://openalex.org/C22979827', 'wikidata': 'https://www.wikidata.org/wiki/Q5137311', 'display_name': 'Cmax', 'level': 3, 'score': 0.48056152}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.46292424}, {'id': 'https://openalex.org/C2779912601', 'wikidata': 'https://www.wikidata.org/wiki/Q1621830', 'display_name': 'Lupus nephritis', 'level': 3, 'score': 0.44598687}, {'id': 'https://openalex.org/C111113717', 'wikidata': 'https://www.wikidata.org/wiki/Q725307', 'display_name': 'Pharmacodynamics', 'level': 3, 'score': 0.41007024}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.32844004}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.23524445}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.183956}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.15238914}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.09652242}, {'id': 'https://openalex.org/C204787440', 'wikidata': 'https://www.wikidata.org/wiki/Q188504', 'display_name': 'Alternative medicine', 'level': 2, 'score': 0.0}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.5086a', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/210.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.5086a', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/210.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.84, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4308071420', 'https://openalex.org/W4291002300', 'https://openalex.org/W3207313530', 'https://openalex.org/W3159937175', 'https://openalex.org/W3135415338', 'https://openalex.org/W2538072326', 'https://openalex.org/W2520778281', 'https://openalex.org/W2149042564', 'https://openalex.org/W2074207917', 'https://openalex.org/W1822154343'], 'abstract_inverted_index': {'Background': [0], 'Orelabrutinib': [1, 13, 370, 411, 412, 413], 'is': [2], 'an': [3], 'oral,': [4], 'highly-selective,': [5], 'irreversible': [6], 'inhibitor': [7], 'of': [8, 20, 34, 45, 75, 87, 177, 183, 213, 225, 308, 314, 328, 350, 391, 495], 'Bruton’s': [9], 'tyrosine': [10], 'kinase': [11], '(BTK).': [12], 'has': [14], 'been': [15], 'approved': [16], 'for': [17, 101, 131, 249, 398], 'the': [18, 42, 64, 97, 246, 266, 306, 312, 483], 'treatment': [19, 165], 'B': [21, 357], 'cell': [22], 'malignancies': [23], 'in': [24, 36, 47, 77, 172, 192, 205, 281, 298, 323, 377, 393, 482], 'China.': [25], 'Two': [26], 'distinct': [27], 'lupus': [28], 'animal': [29], 'models': [30], 'showed': [31], 'significant': [32], 'efficacy': [33, 72, 386, 478, 484], 'orelabrutinib': [35, 46, 76, 122, 178, 226, 285, 332, 367, 392], 'reducing': [37], 'disease': [38, 159], 'activity,': [39], 'which': [40, 214, 304, 387], 'supported': [41], 'clinical': [43], 'development': [44, 390], 'Systemic': [48], 'Lupus': [49], 'Erythematosus': [50], '(SLE).': [51], 'Objectives': [52], 'This': [53, 136], 'phase': [54], 'Ib/IIa,': [55], 'randomized,': [56], 'double-blind,': [57], 'placebo-controlled,': [58], 'dose-finding': [59], 'study': [60, 137], 'aimed': [61], 'to': [62, 81, 119, 256], 'evaluate': [63], 'safety,': [65], 'tolerability,': [66], 'pharmacokinetics': [67], '(PK),': [68], 'pharmacodynamics': [69], '(PD),': [70], 'preliminary': [71], 'and': [73, 113, 154, 175, 186, 228, 245, 279, 291, 326, 338, 354, 359, 374, 395], 'biomarkers': [74], 'patients': [78, 140, 143, 180, 207, 282, 299, 315, 329, 378, 474], 'with': [79, 94, 141, 209, 233, 284, 296, 301, 316, 331, 343, 379], 'mild': [80, 198], 'moderate': [82], 'SLE': [83, 95, 267], 'who': [84, 105, 144, 345], 'received': [85, 346], 'standard': [86], 'care': [88], '(SoC)': [89], 'therapy.': [90], 'Methods': [91], 'Patients': [92, 409], 'diagnosed': [93], 'by': [96], 'ACR': [98], 'classification': [99], 'criteria': [100], '≥': [102], '6': [103, 461], 'months,': [104], 'had': [106], 'a': [107], 'SLEDAI-2K': [108], 'score': [109], '≥5': [110], 'at': [111, 123, 149, 181, 241, 258, 273, 286, 318, 333, 404, 475, 491], 'screening,': [112, 319], 'were': [114, 116, 156, 161, 170, 196, 203, 220, 276, 363, 480], 'autoantibody-positive,': [115], 'randomized': [117, 138], '1:1:1:1': [118], 'receive': [120], 'oral': [121], '50mg,': [124, 184], '80mg,': [125], '100mg': [126, 187, 292, 339], 'or': [127, 199], 'placebo': [128, 193, 302, 347], 'once': [129], 'daily': [130], '12': [132, 275, 477], 'weeks,': [133], 'respectively.': [134], 'Results': [135], '60': [139], '55': [142], 'completed': [145], '12-week': [146], 'treatment.': [147, 368], 'Age': [148], 'baseline': [150], 'was': [151, 215, 230, 239, 371], '33.7±9.8': [152], 'years': [153], '96.7%': [155], 'female.': [157], 'Baseline': [158], 'characteristics': [160], 'generally': [162, 372], 'balanced': [163], 'across': [164], 'groups.': [166], 'Adverse': [167], 'events': [168], '(AEs)': [169], 'reported': [171, 204], '80%,': [173], '93.3%': [174], '100%': [176], 'treated': [179, 208, 283, 300, 330], 'doses': [182], '80mg': [185, 289, 336], 'QD': [188], 'respectively': [189], 'versus': [190], '85.5%': [191], 'group.': [194], 'AEs': [195], 'mostly': [197], 'moderate.': [200], 'Treatment-related': [201], 'SAEs': [202], '3': [206, 455], 'orelabrutinib,': [210], 'only': [211], '1': [212], 'grade': [216], '3.': [217], 'No': [218], 'deaths': [219], 'reported.': [221], 'The': [222], 'plasma': [223], 'exposure': [224], '(AUC': [227], 'Cmax)': [229], 'proportionally': [231], 'increased': [232, 360], 'doses.': [234], 'Nearly': [235], 'complete': [236], 'BTK': [237], 'occupancy': [238, 247], 'achieved': [240], 'all': [242, 263], 'dose': [243], 'levels,': [244], 'lasted': [248], '24': [250], 'hours': [251], 'without': [252], 'any': [253], 'decrease': [254], 'compared': [255, 295, 342], 'that': [257], '4': [259], 'hour': [260], 'post-dosing.': [261], 'In': [262], 'evaluable': [264, 473], 'patients,': [265], 'Response': [268], 'Index': [269], '(SRI)-4': [270], 'response': [271, 321, 489], 'rates': [272, 490], 'week': [274, 405, 476, 492], '50.0%,': [277], '61.5%': [278], '64.3%': [280], '50mg': [287, 334], '(n=14),': [288, 303], '(n=13)': [290], '(n=14)': [293], 'respectively,': [294, 341], '35.7%': [297], 'indicated': [305], 'trend': [307], 'dose-dependent': [309], 'improvement.': [310], 'Among': [311], 'subgroup': [313], 'SLEDAI-2K≥8': [317], 'SRI-4': [320, 425, 451, 488], 'occurred': [322], '70%,': [324], '70%': [325], '66.7%': [327], '(n=10),': [335], '(n=10)': [337], '(n=9),': [340], '30%': [344], '(n=10).': [348], 'Trends': [349], 'reduced': [351], 'proteinuria,': [352], 'anti-dsDNA': [353], 'IgG,': [355], 'total': [356], 'cells': [358], 'complements': [361], 'C4': [362], 'also': [364, 383], 'observed': [365], 'following': [366], 'Conclusion': [369], 'safe': [373], 'well': [375], 'tolerated': [376], 'SLE.': [380, 399], 'Preliminary': [381], 'results': [382, 403], 'suggested': [384], 'encouraging': [385], 'supports': [388], 'further': [389], 'larger': [394], 'longer': [396], 'trials': [397], 'Table': [400], '1.': [401, 487], 'Efficacy': [402], '12.': [406, 493], 'All': [407, 472], 'Evaluable': [408], 'Placebo': [410], '50': [414], 'mg': [415, 417, 419], '80': [416], '100': [418], 'N=55': [420], '14': [421, 422, 424], '13': [423], 'response,': [426, 452], 'n': [427, 453], '(%)': [428, 441, 454, 467], '5': [429], '(35.7%)': [430], '7': [431, 457, 459], '(50.0%)': [432], '8': [433], '(61.5%)': [434], '9': [435, 450], '(64.3%)': [436], 'Treatment': [437, 463], 'difference': [438, 464], 'vs.': [439, 465], 'PBO': [440, 466], '14.3%': [442], '25.8%': [443], '28.6%': [444], 'SLEDAI-2K≥8,': [445], 'N=39': [446], '10': [447, 448, 449], '(30.0%)': [456], '(70.0%)': [458, 460], '(66.7%)': [462], '40.0%': [468, 469], '36.7%': [470], 'Note:': [471], 'data': [479], 'included': [481], 'analysis.': [485], 'Figure': [486], 'Disclosure': [494], 'Interests': [496], 'Ru': [497], 'Li:': [498, 563], 'None': [499, 503, 507, 511, 515, 519, 523, 527, 531, 535, 539, 564], 'declared,': [500, 504, 508, 512, 516, 520, 524, 528, 532, 536, 540], 'Xiaoxia': [501], 'Zhu:': [502], 'Shengyun': [505], 'Liu:': [506, 530], 'Xiao': [509], 'Zhang:': [510], 'Changhao': [513], 'Xie:': [514], 'Zili': [517], 'Fu:': [518], 'Anbin': [521], 'Huang:': [522], 'Lingyun': [525], 'Sun:': [526], 'Dongzhou': [529], 'Jinxia': [533], 'Zhao:': [534], 'Lin': [537], 'Wu:': [538], 'Zhoushuai': [541], 'Qin': [542], 'Employee': [543, 550, 557], 'of:': [544, 551, 558], 'InnoCare': [545, 552, 559], 'Pharma': [546], 'Limited.,': [547, 554, 561], 'Sichen': [548], 'Li': [549], 'pharma': [553, 560], 'Yaorong': [555], 'Liu': [556], 'Zhanguo': [562], 'declared': [565]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4290997406', 'counts_by_year': [{'year': 2024, 'cited_by_count': 5}], 'updated_date': '2025-01-12T10:32:43.747501', 'created_date': '2022-08-13'}